Dr Reddy's Laboratories Limited together with its subsidiaries, had launched the recommended public offer to acquire all the issued and outstanding shares of OctoPlus NV, a service-based specialty pharmaceutical company, at an offer price of Euro 0.52 (cum dividend) per share. The company had announced to acquire OctoPlus Euro 27.39 million in cash. OctoPlus is a Dutch pharma company focused on the development and manufacturing of improved injectable pharmaceuticals based on proprietary drug delivery technologies. The acquisition would help the company in ramping up technology capabilities in drug delivery.
No comments:
Post a Comment